Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × OTHER_GOV × Erlotinib Hydrochloride × Clear all

Phase

Status

Unknown 7 Terminated 1 Suspended 1

Sponsor Class

OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

zanubrutinib 1 osimertinib 1 Vincristine 1 Trastuzumab 1 Rituximab 1 Quality of Life 1 Prednisone 1 Nutritional Status 1 Microscopy, Confocal 1 Interviews as Topic 1 Heparin 1 Exercise 1 Erlotinib Hydrochloride 1 Epirubicin 1 Enoxaparin 1 Docetaxel 1 Cyclophosphamide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01320501 2016-05-13

REALME

National Guard Health Affairs

Phase 4 Suspended

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡